Synopsys, Inc. $SNPS Shares Purchased by Temasek Holdings Private Ltd

Temasek Holdings Private Ltd increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS) by 28.8% during the first quarter, Holdings Channel reports. The institutional investor owned 71,676 shares of the semiconductor company’s stock after acquiring an additional 16,034 shares during the period. Temasek Holdings Private Ltd’s holdings in Synopsys were worth $28,418,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Sankala Group LLC purchased a new position in Synopsys in the fourth quarter valued at about $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Synopsys during the 4th quarter worth approximately $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Synopsys in the 4th quarter worth approximately $28,000. Atlas Capital Advisors Inc. acquired a new stake in shares of Synopsys in the 4th quarter worth approximately $32,000. Finally, Geneos Wealth Management Inc. increased its stake in Synopsys by 151.5% in the 1st quarter. Geneos Wealth Management Inc. now owns 83 shares of the semiconductor company’s stock valued at $33,000 after purchasing an additional 50 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Mizuho said Moonshot AI’s Kimi K3 release reinforces, rather than weakens, the case for agentic AI and could benefit EDA software leaders like Synopsys, prompting a “buy the dip” view after the recent selloff. Buy the dip in EDA stocks as Kimi K3 boosts agentic AI thesis: Mizuho
• Positive Sentiment: Another analysis argued Synopsys should benefit regardless of which companies win the AI race, since AI development across the industry still requires chip-design software and infrastructure. Synopsys Should Benefit No Matter Who Wins The AI Race. Here’s What Explains Its Poor Stock Performance.
• Neutral Sentiment: Technical-trading coverage said SNPS was testing an important price level and had shown signs of stabilization, suggesting traders may be watching for a reversal rather than reacting to a new business catalyst. Stock Of The Day: Will Synopsys Reverse?
• Neutral Sentiment: Broader market headlines also mentioned SNPS in the context of a firmer futures market, which may have helped sentiment somewhat, but did not add company-specific news. Stock Market Today: S&P 500, Dow Jones Futures Gain as Trump Says Iran is ‘Very, Very Badly Damaged’— Eva Live, RTX, Synopsys in Focus

Synopsys Price Performance

SNPS stock opened at $389.07 on Wednesday. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43. The stock’s 50 day moving average price is $464.07 and its 200 day moving average price is $457.23. The firm has a market cap of $74.50 billion, a P/E ratio of 90.06, a PEG ratio of 2.22 and a beta of 1.22.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping the consensus estimate of $3.15 by $0.20. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue was up 41.9% compared to the same quarter last year. During the same quarter last year, the business posted $3.67 earnings per share. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

SNPS has been the subject of several research reports. Needham & Company LLC reaffirmed a “buy” rating and set a $580.00 price objective on shares of Synopsys in a report on Thursday, May 28th. Rosenblatt Securities upped their target price on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. Wells Fargo & Company raised their price target on Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a research report on Thursday, May 28th. BNP Paribas Exane lifted their price target on Synopsys from $425.00 to $450.00 and gave the stock an “underperform” rating in a research note on Thursday, May 28th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a research note on Monday, June 8th. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $570.06.

Insiders Place Their Bets

In related news, CFO Shelagh Glaser sold 3,394 shares of the stock in a transaction on Friday, June 12th. The stock was sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by company insiders.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front?end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape?out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.